Jochen SCHMITZ, n/a

Immunology & Respiratory Disease Research, Boehringer Ingelheim Pharmaceuticals, Inc
Ridgefield, Connecticut, United States

Presentation(s):

• 2486: In Vitro Antifibrotic Effects of Nerandomilast on Cell Types Relevant to Intestinal Remodeling and Fibrosis in Systemic Sclerosis

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.